News
To navigate the post-LDC era successfully, Bangladesh must transition from a volume-driven, generics-dominated model to one ...
The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...
India had refused accept demands from the UK and Switzerland for data exclusivity to protect generic pharma industry, with ...
Basilea has acquired the global rights for Venatorx Pharmaceuticals’ ceftibuten-ledaborbactam etzadroxil, an antibiotic being ...
India and China are set to discuss a trade package focusing on essential commodities like rare earth magnets, fertilizers, ...
Commerce Secretary Howard Lutnick originally stated the investigation should be completed by mid-June. However, a new report from Reuters says that any official announcement on tariffs is still weeks ...
Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...
The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.
The National Institute for Pharmaceutical Research and Development (NIPRD) has called for stronger coordination, longer policy timelines, and improved industry awareness to accelerate local medicine ...
No additional tariffs have been imposed on Indian exports to the United States in key sectors such as pharmaceuticals and ...
Apertura Gene Therapy has entered several licensing agreements to advance CNS treatments using its TfR1 CapX technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results